The invention discloses a method for testing the non-inferior performance of a new
drug when
curative effect data obeys partial normal distribution, aiming at the condition that the
curative effect data obeys partial normal distribution, the non-inferior performance of the new
drug is tested so as to determine the non-inferior performance of the new
drug relative to a standard drug, and meanwhile, the reliability of a detection result is ensured. The method comprises the following steps: S1, acquiring drug
curative effect data in
clinical tests: in a three-arm non-inferior clinical test, based on drug curative effect indexes, respectively acquiring drug curative effect data of three groups of clinical test results of a new
drug group, a standard
drug control group and a
placebo control group, the curative effect data obeying partial normal distribution; s2, probability calculation of first-class errors: in the three-arm non-inferior
hypothesis test model, a frequency method or a Bayesian method is used to calculate the drug curative effect data of the three groups of test results to obtain the probability of first-class errors, and the probability of first-class errors is the probability of occurrence of a standby
hypothesis H1 when an original
hypothesis H0 is established; and S3, non-inferior determination of the new drug: if the probability of making the first type of errors is greater than a given reference value, determining that the new drug has non-inferior relative to the standard drug, and the reference value is a critical value which is given in advance and has
clinical significance.